Looks like it might keep the low of 1.60. Anyone who's still holding shares from over $5 who don't have extended hours trading will probably just hold them now, no point in a massive sell off at open.
Anyone think this might be a good entry point? Down 70%? It's not like they are going bankrupt. Anyone think this one's a bit oversold and market open might be a good time to pick up?
Probably see a good bounce from it. But I haven't done any research on the company. If that was their only promising product, it's unlikely you'll see too high of a bounce.
NEW YORK (Dow Jones)--Acadia Pharmaceuticals Inc. (ACAD) and partner Biovail Corp. (BVF) said Tuesday that the Parkinson's disease psychosis drug they're co-developing failed to meet its top goal in a late-stage clinical trial, a significant blow to Acadia's most advanced product and the biopharmaceutical's fundamentals.